Tricida, Inc.
TCDANASDAQHealthcare
$0.11
+$0.00(+0.00%)
Market Cap$5952334
P/E Ratio—
52W High$13.85
52W Low$0.0411
Tricida, Inc.（TCDA）股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · TCDA · 截至 Jun 9, 2026
关键指标
探索 Tricida, Inc. 数据
tcda stock data · financials竞争对手与同行
tcda competitors#TickerCompanyPriceChangeMkt Cap
#1TCDATricida, Inc.
$0.11+0.00%$6.0M#2
APTOAptose Biosciences Inc.
$1.71+100.00%$4.4M#3
BVXVBiondVax Pharmaceuticals Ltd.
$1.36+0.74%$5.0M#4
ENTOEntero Therapeutics, Inc.
$2.85-5.00%$13.6M#5
FRTXFresh Tracks Therapeutics, Inc.
$0.94-0.53%$5.6M#6
GMDAGamida Cell Ltd.
$0.03+0.00%$4.3M关于 Tricida, Inc.
Tricida, Inc. operates as a biopharmaceutical firm with a primary focus on the advancement and market introduction of veverimer (TRC101). This compound, an orally ingested, non-systemic polymer, has s…
what is tricida, inc. · tcda stock overview · tricida, inc. company profile · who is tricida, inc. ceo · tcda NASDAQ · tricida, inc. headquarters · tricida, inc. business segments
关于股票概览与关键数据
Tricida, Inc.（TCDA）是 Biotechnology 行业的 Healthcare 类公司，于 Jun 28, 2018 在 NASDAQ 上市。截至最近交易日，TCDA 股价为 $0.11，市值约为 $6.0M。过去12个月累计回报 —，年初至今回报 —。
常见问题
截至最近一个交易日，Tricida, Inc.（TCDA）股价为 $0.11，在 NASDAQ 上市，52周区间为 $0.04 – $13.85。
TCDA 最新股价TCDA quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议